Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if the oral intake of the dietary supplement SAMe increases blood homocysteine levels in healthy human subjects.

Clinical Trial Description

S-adenosyl-L-methionine (SAMe or AdoMet) is a commonly used nutritional supplement available in the United States since 1999. SAMe is metabolized to homocysteine, a known cardiovascular risk factor. No study has determined the effect exogenous SAMe administration has on the long-term levels of homocysteine in humans. As a nutritional supplement, SAMe is not regulated by the Food and Drug Administration, despite being used to treat clinical diseases such as depression and osteoarthritis. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Heart Disease

Clinical Trial Details

NCT number	NCT00284011
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	June 2005
Completion date	May 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03481322` - Low Sodium Cooking Study	N/A
Completed	`NCT00001638` - Magnetic Resonance Imaging of the Blood Vessels of the Heart
Completed	`NCT02376244` - The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation	N/A
Completed	`NCT02523144` - Dexmedetomidine in Children Having Transthoracic Echocardiography	Phase 4
Completed	`NCT02277379` - Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery	N/A
Completed	`NCT01871090` - Remote Device Interrogation In The Emergency Department	N/A
Completed	`NCT02045641` - Pleural and Pericardial Effusion Following Open Heart Surgery	N/A
Active, not recruiting	`NCT01400490` - Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study	N/A
Completed	`NCT01192360` - Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease	Phase 3
Terminated	`NCT00935766` - Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries	Phase 3
Completed	`NCT00745446` - The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation	N/A
Completed	`NCT00140816` - Dairy Products and Metabolic Effects (Norwegian Part)	N/A
Completed	`NCT00178620` - Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization	Phase 4
Completed	`NCT00013949` - Cardiovascular Vulnerability to Particulate Exposure	N/A
Completed	`NCT01952171` - The Genetic Basis of Congenital Heart Disease in Africa
Recruiting	`NCT02933892` - Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization	Phase 4
Withdrawn	`NCT02838355` - Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients	N/A
Completed	`NCT02923518` - Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes)
Terminated	`NCT02282163` - Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography	Phase 3
Active, not recruiting	`NCT02260466` - Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.	N/A